Literature DB >> 20936479

Protection against increased intestinal permeability and bacterial translocation induced by intestinal obstruction in mice treated with viable and heat-killed Saccharomyces boulardii.

Simone V Generoso1, Mirelle L Viana, Rosana G Santos, Rosa M E Arantes, Flaviano S Martins, Jacques R Nicoli, José A N Machado, Maria Isabel T D Correia, Valbert N Cardoso.   

Abstract

BACKGROUND: There are substantial evidences suggesting that probiotics can protect the gastrointestinal tract against inflammatory or infectious episodes. The effects of oral treatment with viable or heat-killed cells of Saccharomyces boulardii (Sb) on bacterial translocation, intestinal permeability, histological aspect of the ileum, and some immunological parameters were evaluated in a murine intestinal obstruction (IO) model.
RESULTS: Bacterial translocation and intestinal permeability in the IO group were significantly higher when compared to a Sham group (p < 0.05). Pretreatment with both viable and heat-killed S. boulardii prevented these increases, and the data obtained for IO + Sb and IO + heat-killed Sb groups were similar to those observed in the Sham group (p > 0.05). Histological analysis showed preservation of the ileum mucosa in mice that received both forms of the yeast when compared to the lesions observed in the IO group. The levels of serum interleukin (IL)-10 and intestinal secretory immunoglobulin A (sIgA) were higher in the animals that received both yeast treatments when compared to those from IO and Sham groups.
CONCLUSION: Oral treatment with viable or heat-killed cells of S. boulardii maintained intestinal integrity and modulated the immune system in a murine IO model, preventing bacterial translocation and intestinal lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936479     DOI: 10.1007/s00394-010-0134-7

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  46 in total

1.  Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice.

Authors:  A C Rodrigues; D C Cara; S H Fretez; F Q Cunha; E C Vieira; J R Nicoli; L Q Vieira
Journal:  J Appl Microbiol       Date:  2000-09       Impact factor: 3.772

2.  Patterns of bacterial translocation in experimental biliary obstruction.

Authors:  J S White; M Hoper; R W Parks; W D B Clements; T Diamond
Journal:  J Surg Res       Date:  2005-09-08       Impact factor: 2.192

3.  Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells.

Authors:  D Czerucka; S Dahan; B Mograbi; B Rossi; P Rampal
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Bacterial [correction of baterial] translocation in humans.

Authors:  S M Lichtman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-07       Impact factor: 2.839

5.  The impact of arginine on bacterial translocation in an intestinal obstruction model in rats.

Authors:  Iara Eliza Pacífico Quirino; Maria Isabel Toulson Davisson Correia; Valbert Nascimento Cardoso
Journal:  Clin Nutr       Date:  2007-02-16       Impact factor: 7.324

Review 6.  Biotherapeutic agents in the treatment of infectious diarrhea.

Authors:  G W Elmer; L V McFarland
Journal:  Gastroenterol Clin North Am       Date:  2001-09       Impact factor: 3.806

Review 7.  Mechanisms of action of probiotics: recent advances.

Authors:  S C Ng; A L Hart; M A Kamm; A J Stagg; S C Knight
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

Review 8.  Safety of probiotics: translocation and infection.

Authors:  Min-Tze Liong
Journal:  Nutr Rev       Date:  2008-04       Impact factor: 7.110

Review 9.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis.

Authors:  Aloysius L D'Souza; Chakravarthi Rajkumar; Jonathan Cooke; Christopher J Bulpitt
Journal:  BMJ       Date:  2002-06-08

10.  Probiotics partly reverse increased bacterial translocation after simultaneous liver resection and colonic anastomosis in rats.

Authors:  Daniel Seehofer; Nada Rayes; Reinhard Schiller; Martin Stockmann; Andrea R Müller; Anja Schirmeier; Frank Schaeper; Stefan G Tullius; Stig Bengmark; Peter Neuhaus
Journal:  J Surg Res       Date:  2004-04       Impact factor: 2.192

View more
  14 in total

Review 1.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation.

Authors:  Chao Yue; Bingqiang Ma; Yunzhao Zhao; Qiurong Li; Jieshou Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

Review 3.  Postbiotics as the key mediators of the gut microbiota-host interactions.

Authors:  Mahdi Asghari Ozma; Amin Abbasi; Sousan Akrami; Masoud Lahouty; Nayyer Shahbazi; Khudaverdi Ganbarov; Pasquale Pagliano; Sahar Sabahi; Şükran Köse; Mehdi Yousefi; Sounkalo Dao; Mohammad Asgharzadeh; Hedayat Hosseini; Hossein Samadi Kafil
Journal:  Infez Med       Date:  2022-06-01

4.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

5.  Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.

Authors:  Lauren E Hudson; Milo B Fasken; Courtney D McDermott; Shonna M McBride; Emily G Kuiper; David B Guiliano; Anita H Corbett; Tracey J Lamb
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

6.  Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers.

Authors:  Brian K McFarlin; Andrea L Henning; Erin M Bowman; Melody A Gary; Kimberly M Carbajal
Journal:  World J Gastrointest Pathophysiol       Date:  2017-08-15

Review 7.  More of the Gut in the Lung: How Two Microbiomes Meet in ARDS.

Authors:  Samiran Mukherjee; Dusan Hanidziar
Journal:  Yale J Biol Med       Date:  2018-06-28

Review 8.  The role of probiotics and prebiotics in inducing gut immunity.

Authors:  Angélica T Vieira; Mauro M Teixeira; Flaviano S Martins
Journal:  Front Immunol       Date:  2013-12-12       Impact factor: 7.561

9.  Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice.

Authors:  Tatiani Uceli Maioli; Brenda de Melo Silva; Michelle Nobre Dias; Nivea Carolina Paiva; Valbert Nascimento Cardoso; Simone Odilia Fernandes; Cláudia Martins Carneiro; Flaviano Dos Santos Martins; Simone de Vasconcelos Generoso
Journal:  J Negat Results Biomed       Date:  2014-04-11

10.  Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice.

Authors:  Huan Zhou; Hui-Jing Zhang; Lin Guan; Yi-Ning Zhang; Yue Li; Ming-Jun Sun
Journal:  Mol Med Rep       Date:  2018-10-30       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.